^Zurich and Boston, June 02, 2025 (Globe Newswire) – Biognosys, a worldwide
The leading provider of mass spectrome -based proteomic solutions gives
Introduction of Spectronaut (®) 20 and Spectromine ((TM)) 5 on the ASMS 2025 Annual
Conference known, which takes place from June 1 to 5 in Baltimore, Maryland.
These extensive software updates provide important technological
Progress in the areas of non -specific search performance, immunopeptidomics and
Cloud-capable Proteomic workflows.
The heart of the new versions is Kuiper, the new search engine of
Biaognosys based on proprietary predictive models that specifically for
unspecific search queries have been optimized. Kuiper delivers record -breaking
Peptididalizations, especially for applications in immunopeptideomics.
Most important features of Spectronaut (®) 20:
* Up to 80 % more peptididitis in immunopeptidomic-hella-class
Workflows
* Accelerated processing with Directdia (®) runtime improvements
* Improved quantitative accuracy for timstof data through algorithms,
that react to ion mobility
* Extended FDR and quality controller options
* Improved data visualization, Linux support and cloud
compatibility
* Availability on Bruker ProteoScape ((TM)) and thus expansion of the
Possibilities for immunopeptidomics and analysis
Post -translational modifications
Kuiper also supports Spectromines (TM) 5, the latest version of Biognosys for
DDA-based proteomics, which now improved significantly
Provides identification performance. With the newly added Linux support
Supplements Spectromine Spectronaut and now enables the analysis of
Proteomic data with high throughput in cloud and high-performance computer environments
(HPC) – for scalable research workflows of the next generation.
The uses of the next generation of Biognosys software
are based on several scientific posters and in the context of two
Breakfast seminars and workshops presented. This includes two common
Presentations with Greywolf therapeutics on advanced immunopeptidomics
Workflows and contributions to a workshop on best practice guidelines for
the reporting on slide data.
Biognosys will also present his latest technological innovation that
P2 Enrichment System – a robust plasma based on nanoparticles
Workflow, the unprecedented depth, reproducibility and throughput rate in
the plasma prototomic offers. The P2-
System is on a new scientific poster and in a presentation
presented by employees of the Johns Hopkins School of Medicine. Her
Research results prove the practical applicability of P2 in a
Clinical study on the discovery of circulating biomarkers for the early
Detection of neurodegenerative diseases.
Biognosys was also invited to a lecture on Proteoverse (®)
To keep digital proteome, the company’s own proteome expression atlas for
Several tissue and species. As one of the most comprehensive resources of its kind
he offers valuable insights into the proto -landscape of humans and
Preclinical species and thus supports top research in the areas
Pharmaceutical development and translational science.
? Immunopeptidomics are crucial for understanding how ours
Therapeutics work in patients. Spectronaut 20 enables us to complex
To analyze data records faster and deeper and important knowledge about
the MHC-I-antigen modulation and its effects on immune recognition
Win, “said Dr. Daniel Green, Head of Bioinformatics at Greywolf
Therapeutics.
Biognosys’s P2 enrichment system was made smooth in our laboratory on
Broad institutes integrated .? We were impressed by the clarity and
Robustness of the protocols as well as the extraordinary performance of the
Technology in all of our rehearsals, “said Dr. Steven A. Carr, Senior Director
of Proteomics and Institute Scientist at the Broad Institute of Mit and Harvard.
Further information on the scientific presence of biognosys on the ASMS
2025 can be found at: https://biognosys.com/conferences/73rd-asms-conference-
2025/
Via Spectronaut (®)
Spectronaut is the leading data analysis software from Biognosys for the
Data-independent acquisition (DIA) of mass spectrometry (MS)-based
Proteomic data. The software uses advanced algorithms for search and
Artificial intelligence (AI) to use data into usable knowledge for the
to transform bioscientific research. Spectronaut enables the
Reproducible and precise quantification of thousands of proteins in one
The only experiment and offers multidimensional insights into protein expression,
-function and structure in all important biological species and
Problem types. You can find more information at www.spectronaut.com
(http://www.spectronaut.com/).
About biognosys
Biognosys is a leading order research institute (CRO) that is on
Proteomic services for F&E in the early phase to monitoring
Biomarkers specialize in clinical studies. In cooperation with the
The most innovative biotech and pharmaceutical company worldwide sets biognosys
Unique, patented technologies and high -resolution mass spectrometry
a to quantify thousands of proteins with unsurpassed
To enable precision, depth and throughput. Biognosys has
Laboratories near Zurich (Switzerland) and Boston (Massachusetts) and
Links scientific competence with proteomics of the next generation to
to accelerate the discovery and development of medication and the
Translational and preclinical research as well as clinical studies for the
To support precision medicine. You can find more information at
www.biognosys.com (http://www.biognosys.com/)
Media contacts
Dr. Kristina Beeler
Chief Product Development and Marketing Officer
[email protected] (mailto: [email protected])
The starting language in which the original text is published is that
official and authorized version. Translations become better
Communication included. Only the language version that in the original
was published. So they are compared with translations
the original language version of the publication.
 °